Clinical Trials
7 trialsNCT04794127 2026-02-18
TRABEPIO
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT02821507 2022-04-20
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Leiden University Medical Center
Phase 2 Completed
NCT02106312 2021-08-04
DOREMY
The Netherlands Cancer Institute
Phase 2 Unknown
NCT03989596 2021-02-01
SINDIR
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Unknown
NCT03651375 2021-01-22
UN-RESARC
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Unknown
NCT03397186 2019-09-10
Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
Fred Hutchinson Cancer Center
Phase 2 Withdrawn
NCT03816475 2019-06-17
LIPOMYX
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Unknown